Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis
Daniel Wendling, Cédric Lukas, Julien Paccou, et al.
Joint Bone Spine (2014) Vol. 81, Iss. 1, pp. 6-14
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Specific Management of Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion Island from 2006-2012
Émilie Javelle, Anne Ribéra, I. Degasne, et al.
PLoS neglected tropical diseases (2015) Vol. 9, Iss. 3, pp. e0003603-e0003603
Open Access | Times Cited: 219
French guidelines for the management of chikungunya (acute and persistent presentations). November 2014
Fabrice Simon, Émilie Javelle, André Cabié, et al.
Médecine et Maladies Infectieuses (2015) Vol. 45, Iss. 7, pp. 243-263
Open Access | Times Cited: 202
2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis
Daniel Wendling, Cédric Lukas, Clément Prati, et al.
Joint Bone Spine (2018) Vol. 85, Iss. 3, pp. 275-284
Closed Access | Times Cited: 87
Chikungunya: risks for travellers
Fabrice Simon, Éric Caumes, Tomáš Jelı́nek, et al.
Journal of Travel Medicine (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 35
Role of the Gut Microbiota in Osteoarthritis, Rheumatoid Arthritis, and Spondylarthritis: An Update on the Gut–Joint Axis
Umile Giuseppe Longo, Alberto Lalli, Benedetta Bandini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3242-3242
Open Access | Times Cited: 13
Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada
Claire E.H. Barber, Deborah A. Marshall, Dianne Mosher, et al.
The Journal of Rheumatology (2016) Vol. 43, Iss. 3, pp. 530-540
Open Access | Times Cited: 71
Spondyloarthritis: A concept or a disease?
Daniel Wendling, Pascal Claudepierre, Clément Prati, et al.
Joint Bone Spine (2015) Vol. 82, Iss. 6, pp. 387-389
Closed Access | Times Cited: 39
The IL-23/Th 17 pathway in spondyloarthritis: The Royal Road?
Daniel Wendling, Xavier Guillot, Clément Prati
Joint Bone Spine (2014) Vol. 82, Iss. 1, pp. 1-4
Closed Access | Times Cited: 38
The gut in spondyloarthritis
Daniel Wendling
Joint Bone Spine (2016) Vol. 83, Iss. 4, pp. 401-405
Closed Access | Times Cited: 35
The Effect of Comedication With a Conventional Synthetic Disease‐Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti–Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis
Michael J. Nissen, Adrian Ciurea, Jürg Bernhard, et al.
Arthritis & Rheumatology (2016) Vol. 68, Iss. 9, pp. 2141-2150
Open Access | Times Cited: 34
Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
Т. В. Дубинина, Ш. Ф. Эрдес
Rheumatology Science and Practice (2025) Vol. 63, Iss. 2, pp. 129-137
Open Access
Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis
Rebecca Shin-Yee Wong
Advances in Pharmacological Sciences (2019) Vol. 2019, pp. 1-6
Open Access | Times Cited: 28
Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience
Anne-Sophie Soubrier, Peggy Bele-Philippe, Bernard Cortet, et al.
Joint Bone Spine (2014) Vol. 82, Iss. 1, pp. 31-37
Closed Access | Times Cited: 24
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies
Francesco Caso, Luisa Costa, Antonio Del Puente, et al.
Therapeutic Advances in Chronic Disease (2015) Vol. 6, Iss. 6, pp. 328-338
Open Access | Times Cited: 22
M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage
Jinzhu Zhao, Wei Yuan, Chunsheng Tao, et al.
Apmis (2017) Vol. 125, Iss. 12, pp. 1070-1075
Closed Access | Times Cited: 22
Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome
J. Corli, René‐Marc Flipo, Peggy Philippe, et al.
The Journal of Rheumatology (2015) Vol. 42, Iss. 12, pp. 2376-2382
Closed Access | Times Cited: 21
Treating to target in axial spondyloarthritis: defining the target and the arrow
Daniel Wendling
Expert Review of Clinical Immunology (2015) Vol. 11, Iss. 6, pp. 691-693
Closed Access | Times Cited: 19
An overview of investigational new drugs for treating ankylosing spondylitis
Daniel Wendling
Expert Opinion on Investigational Drugs (2015) Vol. 25, Iss. 1, pp. 95-104
Closed Access | Times Cited: 18
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development
Jamal Mikdashi
Rheumatic Disease Clinics of North America (2022) Vol. 48, Iss. 3, pp. 691-703
Closed Access | Times Cited: 11
Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients
C. Jacquemin, Walter P. Maksymowych, Annelies Boonen, et al.
The Journal of Rheumatology (2016) Vol. 44, Iss. 4, pp. 425-430
Closed Access | Times Cited: 17
Flare in spondyloarthritis: Thresholds of disease activity variations
Marie Godfrin-Valnet, Marc Puyraveau, Clément Prati, et al.
Joint Bone Spine (2015) Vol. 82, Iss. 3, pp. 192-195
Closed Access | Times Cited: 14
Remission is related to CRP and smoking in early axial spondyloarthritis. The DESIR cohort
Daniel Wendling, Xavier Guillot, Laure Gossec, et al.
Joint Bone Spine (2016) Vol. 84, Iss. 4, pp. 473-476
Closed Access | Times Cited: 14
Spondyloarthritis and the gut: A new look
Daniel Wendling, Lucine Vuitton, Stéphane Koch, et al.
Joint Bone Spine (2015) Vol. 82, Iss. 2, pp. 77-79
Closed Access | Times Cited: 13
Evaluation of physiotherapy in a prospective cohort of early axial spondyloarthritis. Data from the DESIR cohort
C. Escalas, Marie Dalichampt, Maxime Dougados, et al.
Joint Bone Spine (2015) Vol. 83, Iss. 2, pp. 185-190
Closed Access | Times Cited: 12
Remission in axial spondyloarthritis: The ultimate treatment goal?
Daniel Wendling, Clément Prati
Joint Bone Spine (2015) Vol. 83, Iss. 2, pp. 117-119
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top